Q8CFM6
Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 175 kDa stabilin-2 (175 kDa hyaluronan receptor for endocytosis)]
Domain Architecture(16 domains)
Q8CFM6_F1_nD13(916-945)Q8CFM6_F1_nD2(196-250)Q8CFM6_F1_nD11(816-865)Q8CFM6_F1_nD18(1176-1313)Q8CFM6_F1_nD4(296-335)Q8CFM6_F1_nD7(421-460)Q8CFM6_F1_nD15(991-1030)Q8CFM6_F1_nD1(6-135)Q8CFM6_F1_nD8(461-590)Q8CFM6_F1_nD5(336-380)Q8CFM6_F1_nD6(381-420)Q8CFM6_F1_nD17(1061-1155)Q8CFM6_F1_nD9(596-750)Q8CFM6_F1_nD10(756-810)Q8CFM6_F1_nD16(1036-1055,1156-1175)Q8CFM6_F1_nD14(946-990)
3D Structure
Loading viewer...
Domain Details
| # | Domain ID | Range | X-group | H-group | T-group | Family |
|---|---|---|---|---|---|---|
| 1 | Q8CFM6_F1_nD13 | 916-945 | 389 | 389.1 | 389.1.1 | |
| 2 | Q8CFM6_F1_nD2 | 196-250 | 389 | 389.1 | 389.1.1 | 389.1.1.1(EGF) |
| 3 | Q8CFM6_F1_nD11 | 816-865 | 389 | 389.1 | 389.1.1 | 389.1.1.49(EGF_Teneurin) |
| 4 | Q8CFM6_F1_nD18 | 1176-1313 | 239 | 239.3 | 239.3.1 | 239.3.1.1(Fasciclin) |
| 5 | Q8CFM6_F1_nD4 | 296-335 | 389 | 389.1 | 389.1.1 | 389.1.1.16(EGF_3) |
| 6 | Q8CFM6_F1_nD7 | 421-460 | 389 | 389.1 | 389.1.1 | 389.1.1.16(EGF_3) |
| 7 | Q8CFM6_F1_nD15 | 991-1030 | 389 | 389.1 | 389.1.1 | 389.1.1.16(EGF_3) |
| 8 | Q8CFM6_F1_nD1 | 6-135 | 239 | 239.3 | 239.3.1 | 239.3.1.1(Fasciclin) |
| 9 | Q8CFM6_F1_nD8 | 461-590 | 239 | 239.3 | 239.3.1 | 239.3.1.1(Fasciclin) |
| 10 | Q8CFM6_F1_nD5 | 336-380 | 389 | 389.1 | 389.1.1 | 389.1.1.16(EGF_3) |
| 11 | Q8CFM6_F1_nD6 | 381-420 | 389 | 389.1 | 389.1.1 | 389.1.1.16(EGF_3) |
| 12 | Q8CFM6_F1_nD17 | 1061-1155 | 209 | 209.1 | 209.1.1 | 209.1.1.4(Xlink) |
| 13 | Q8CFM6_F1_nD9 | 596-750 | 239 | 239.3 | 239.3.1 | 239.3.1.1(Fasciclin) |
| 14 | Q8CFM6_F1_nD10 | 756-810 | 872 | 872.1 | 872.1.1 | |
| 15 | Q8CFM6_F1_nD16 | 1036-1055,1156-1175 | 389 | 389.1 | 389.1.1 | 389.1.1.16(EGF_3) |
| 16 | Q8CFM6_F1_nD14 | 946-990 | 389 | 389.1 | 389.1.1 | 389.1.1.16(EGF_3) |